Tag: hpv vaccine

1. Among a cohort of college-age young adults, having appropriate knowledge of the HPV vaccine was associated with increased uptake, while high uncertainty was associated with decreased uptake. Evidence Rating Level: 2 (Good) Study Rundown: Human papillomavirus (HPV) is the most common sexually transmitted infection in the U.S., and can lead...
1. Human papillomavirus (HPV) vaccine decreased infection rates among vaccinated women by 70-80%, depending on vaccine type 2. Infection with 4-valent vaccine-type HPV among unvaccinated women also decreased by about 40%. Study Rundown: Current literature suggests HPV infection is linked to several types of female and male genital, anal, and oropharyngeal...
1. Physicians who used an announcement technique when introducing human papillomavirus (HPV) vaccination had a higher rate of vaccination coverage compared to other techniques. 2. The announcement technique involves stating that vaccinations will be given without inviting questions from patients. Evidence Rating Level: 1 (Excellent)             Study Rundown: Vaccine uptake for the...
1. A greater proportion of teenage girls initiated the human papillomavirus (HPV) vaccine series in states where the tetanus, diphtheria, and pertussis (Tdap) booster and/or the meningococcal vaccine were required for school entry. 2. State laws requiring HPV vaccination but allowing for exemptions for any reason have not been effective...
1. In U.S. adolescent males, human papillomavirus (HPV) vaccination uptake of ≥1 dose and series completion of ≥3 doses were 34.6% and 13.9%, respectively, with significantly higher rates of completion among non-Hispanic blacks and Hispanics, compared with non-Hispanic whites. 2. The most common reason reported by parents for not vaccinating...
1. Simultaneous administration of the 9-valent human papillomavirus (HPV) vaccine with Tdap (tetanus/diphtheria/acellular pertussis) and Menactra (Neisseria meningitidis) resulted in a noninferior antibody response compared to non-simultaneous injections. 2. There was no statistical difference in vaccine-related serious adverse events between the two groups, although concomitant injection did result in more...
1. From a cross-sectional study of women aged 15-25 years, women who self-identified as lesbians and had heard of the HPV vaccine were less likely to have initiated vaccination than heterosexuals. 2. Women who did not report their sexual orientation, predominantly Latina immigrants of lower socioeconomic status, were significantly less...
1. Relative to non-vaccinated girls, there was no increase in rates of sexually transmitted infections (STIs) following HPV vaccination. Evidence Rating Level: 2 (Good)   Study Rundown: Nearly 25 percent of girls ages 14-19 and 45 percent of girls ages 20-24 are affected by human papillomavirus (HPV) each year. HPV is...
1. This cohort study demonstrated no increased risk of multiple sclerosis (MS) among girls and women who received the quadrivalent human papillomavirus (HPV) vaccine in Denmark and Sweden. 2. This cohort study additionally demonstrated no increased risk of other, non-MS demyelinating diseases of the central nervous system among girls and...
1. Among preadolescents and adolescents treated with HPV4 quadrivalent vaccine, anti-HPV seropositivity persisted through 96 months post-vaccination. 2. No new significant adverse events were observed over 8 years post-vaccination. Evidence Rating Level: 1 (Excellent)  Study Rundown: There are specific strains of the human papillomavirus (HPV), a sexually acquired virus, that are known...